Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
New England Journal of Medicine · 08.05.2025 · 392 (18) · 1813-1823
DOI: 10.1056/nejmoa2501440 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 08.05.2025. Verfasst von Luke J Laffin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland. Hauptthemen laut MEDLINE: Antihypertensive Agents, Cytochrome P-450 CYP11B2, Hypertension. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Mineralys Therapeutics, Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland.
- Cleveland Clinic Coordinating Center for Clinical Research, Cleveland.
- Department of Health Systems and Population Health, University of Washington, Seattle.
- Mineralys Therapeutics, Radnor, Pennsylvania.
- Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore.
- Department of Medicine, Morehouse School of Medicine, Atlanta.
ORCID-Profile: Ashish Sarraju, Steven E Nissen
Förderung
- Mineralys Therapeutics, Inc
Zitieren
APA
Laffin, L. J., Kopjar, B., Melgaard, C., Wolski, K., Ibbitson, J., Bhikam, S., Weir, M. R., Ofili, E. O., Mehra, R., Luther, J. M., Cohen, D. L., Sarraju, A., Wilkinson, M. J., Flack, J. M., Rodman, D., Nissen, S. E., & Advance-HTN Investigators (2025). Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension. New England Journal of Medicine, 392(18), 1813-1823. https://doi.org/10.1056/nejmoa2501440
Vancouver
Laffin LJ, Kopjar B, Melgaard C, Wolski K, Ibbitson J, Bhikam S, et al. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension. New England Journal of Medicine. 2025;392(18):1813-1823. doi:10.1056/nejmoa2501440
BibTeX
@article{Laffin2025,
author = {Laffin, Luke J and Kopjar, Branko and Melgaard, Carrie and Wolski, Kathy and Ibbitson, Jessica and Bhikam, Shivani and Weir, Matthew R and Ofili, Elizabeth O and Mehra, Reena and Luther, James M and Cohen, Debbie L and Sarraju, Ashish and Wilkinson, Michael J and Flack, John M and Rodman, David and Nissen, Steven E and Advance-HTN Investigators, Advance-HTN Investigators},
title = {Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {18},
pages = {1813--1823},
doi = {10.1056/nejmoa2501440}
}
EUVIMED